Ole Tietz

Country flagAustralia

Research Interests

Explore related searches

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (9)

Trans‐blood–brain barrier (BBB) delivery of therapeutic and diagnostic agents is a major challenge in the development of central nervous system (CNS) targeted radiopharmaceuticals. This review is an introduction to the use of peptides as delivery agents to transport cargos into the CNS. The most widely used BBB‐penetrating peptides are reviewed here, with a particular emphasis on the broad range of cargos delivered into the CNS using these. Cell‐penetrating peptides (CPPs) have been deployed as trans‐BBB delivery agents for some time; new developments in the CPP field offer exciting opportunities for the design of next generation trans‐BBB complexes. Many of the peptides highlighted here are ready to be combined with diagnostic and therapeutic radiopharmaceuticals to develop highly effective CNS‐targeted agents.

Year:

2023

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (8)

Wei-Li Kuan

Head of Biology

University of Cambridge

UNITED KINGDOM
View details

Abdul Karim Haji Dheere

King’s College London

UNITED KINGDOM
View details

MANUEL SARMIENTO SOTO

Lecturer

Universidad de Sevilla

SPAIN
View details

Sarah Able

University of Oxford

UNITED KINGDOM
View details

Katherine Stott

University of Cambridge

UNITED KINGDOM
View details

Fernando Cortezon-Tamarit

University of Oxford

UNITED KINGDOM
View details

Lars Ittner

Macquarie University

AUSTRALIA
View details

Jessica Kwok

Associate Professor

University of Leeds

UNITED KINGDOM
View details
ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.